1. Decreased serum activity of semicarbazide-sensitive amine oxidase (SSAO) in patients treated with second generation antipsychotics: a link to impaired glucose metabolism?

   • Veit Roessner
   • Annette Weber
   • Stefan Bleich

   Clinical Trial 28 February 2007 Pages: 425 - 429

   

2. British and Canadian views on the ethics of paediatric clinical trials

   • H. M. Sammons
   • J. Malhotra
   • M. J. Rieder

   Clinical Trial 16 March 2007 Pages: 431 - 436

3. Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters

   • Emmanuelle Comets
   • Céline Verstuyft
   • France Mentré

   Pharmacogenetics 13 March 2007 Pages: 437 - 449

   

4. Pharmacokinetic study of the interaction between itraconazole and nevirapine

   • Sutep Jaruratanasirikul
   • Somchai Sriwiriyajan

   Pharmacokinetics 07 March 2007 Pages: 451 - 456

   

5. Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered

   • O. M. S. Minzi
   • A. Gupta
   • L. L. Gustafsson

   Pharmacokinetics and Disposition 27 February 2007 Pages: 457 - 462

   

6. Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen

   • Aleksi Tornio
   • Mikko Niemi
   • Janne T. Backman

   Pharmacokinetics and Disposition 27 February 2007 Pages: 463 - 469

   

7. Does coronary artery bypass surgery affect metoprolol bioavailability

   • Antti Valtola
   • Hannu Kokki
   • Tapio Hakala

   Pharmacokinetics and Disposition 28 February 2007 Pages: 471 - 478

   

8. Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients

   • Somchai Sriwiriyajan
   • Werawath Mahatthanatrakul
   • Sutep Jaruratanasirikul

   Pharmacokinetics and Disposition 08 March 2007 Pages: 479 - 483

   

9. Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

   • Grant Langdon
   • Ivelina Gueorguieva
   • Mats Karlsson

   Pharmacokinetics and Disposition 08 March 2007 Pages: 485 - 498

   

10. Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study

    • Jacob Sode
    • Niels Obel
    • Annmarie Lassen

    Pharmacoepidemiology and Prescription 03 March 2007 Pages: 499 - 503

    

11. Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor

    • Susanna M. Wallerstedt
    • Gertrud Brunlöf
    • Lars Ny

    Pharmacoepidemiology and Prescription 09 March 2007 Pages: 505 - 508

    

12. Adverse drug effects in elderly people – a disparity between clinical examination and adverse effects self-reported by the patient

    • Pasi Lampela
    • Sirpa Hartikainen
    • Risto Huupponen

    Pharmacoepidemiology and Prescription 10 March 2007 Pages: 509 - 515

13. Illusions of objectivity and a recommendation for reporting data mining results

    • Manfred Hauben
    • Lester Reich
    • Muhammad Younus

    Short Communication 16 March 2007 Pages: 517 - 521

14. Placental transfer of bupivacaine enantiomers in normal pregnant women receiving epidural anesthesia for cesarean section

    • Luciana de Barros Duarte
    • Elaine Christine Dantas Móises
    • Sérgio Pereira da Cunha

    Letter to the Editors 07 March 2007 Pages: 523 - 526

    

15. No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients

    • Pedro Dorado
    • Roland Berecz
    • Adrián LLerena

    Letter to the Editors 08 March 2007 Pages: 527 - 528